These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8878950)

  • 41. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.
    Scott-Thomas AJ; Syhre M; Pattemore PK; Epton M; Laing R; Pearson J; Chambers ST
    BMC Pulm Med; 2010 Nov; 10():56. PubMed ID: 21054900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenesis of Pseudomonas aeruginosa lung infections in cystic fibrosis.
    Grimwood K
    J Paediatr Child Health; 1992 Feb; 28(1):4-11. PubMed ID: 1554515
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
    Martin DW; Schurr MJ; Mudd MH; Govan JR; Holloway BW; Deretic V
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8377-81. PubMed ID: 8378309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conversion to mucoidy in Pseudomonas aeruginosa.
    Deretic V; Martin DW; Schurr MJ; Mudd MH; Hibler NS; Curcic R; Boucher JC
    Biotechnology (N Y); 1993 Oct; 11(10):1133-6. PubMed ID: 7764093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
    Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
    APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).
    Yu H; Boucher JC; Hibler NS; Deretic V
    Infect Immun; 1996 Jul; 64(7):2774-81. PubMed ID: 8698507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron, Pseudomonas aeruginosa and cystic fibrosis.
    Reid DW; Kirov SM
    Microbiology (Reading); 2004 Mar; 150(Pt 3):516. PubMed ID: 14993297
    [No Abstract]   [Full Text] [Related]  

  • 48. Influence of nutrient media on the chemical composition of the exopolysaccharide from mucoid and non-mucoid Pseudomonas aeruginosa.
    Marty N; Dournes JL; Chabanon G; Montrozier H
    FEMS Microbiol Lett; 1992 Nov; 77(1-3):35-44. PubMed ID: 1459419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
    Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiology of lung infection in cystic fibrosis.
    Govan JR; Nelson JW
    Br Med Bull; 1992 Oct; 48(4):912-30. PubMed ID: 1281036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of exopolysaccharide production by mucoid Pseudomonas aeruginosa.
    Ohman DE; Goldberg JB; Flynn JA; Powell SK
    Antibiot Chemother (1971); 1985; 36():13-22. PubMed ID: 3923910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
    Chotirmall SH; Smith SG; Gunaratnam C; Cosgrove S; Dimitrov BD; O'Neill SJ; Harvey BJ; Greene CM; McElvaney NG
    N Engl J Med; 2012 May; 366(21):1978-86. PubMed ID: 22607135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 56. The purification and chemical characterisation of the alginate present in extracellular material produced by mucoid strains of Pseudomonas aeruginosa.
    Sherbrock-Cox V; Russell NJ; Gacesa P
    Carbohydr Res; 1984 Dec; 135(1):147-54. PubMed ID: 6441642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ballmann M; Rabsch P; von der Hardt H
    Thorax; 1998 Sep; 53(9):732-7. PubMed ID: 10319054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting
    Jorth P; Durfey S; Rezayat A; Garudathri J; Ratjen A; Staudinger BJ; Radey MC; Genatossio A; McNamara S; Cook DA; Aitken ML; Gibson RL; Yahr TL; Singh PK
    Am J Respir Crit Care Med; 2021 Mar; 203(5):637-640. PubMed ID: 33137262
    [No Abstract]   [Full Text] [Related]  

  • 59. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.
    Lyczak JB; Cannon CL; Pier GB
    Microbes Infect; 2000 Jul; 2(9):1051-60. PubMed ID: 10967285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.